Baseline QCA | Cohort A (n=72*) | Cohort B (n=79) |
Target vessel | ||
Left Anterior Decending artery (LAD) | 37 (51.4%) | 41 (51.9%) |
Circumflex artery (Cx) | 22 (30.6%) | 20 (25.3%) |
Right Coronary Artery (RCA) | 13 (18.1%) | 18 (22.8%) |
ACC/AHA lesion classification | ||
Type A | 21 (29.2%) | 9 (11.4%) |
Type B1 | 26 (36.1%) | 44 (55.7%) |
Type B2 | 25 (34.7%) | 22 (28.8%) |
Type C | 0 (0.0%) | 4 (5.1%) |
Reference vessel diameter (mm) | 2.67±0.34 | 2.74±0.34 |
Lesion length (mm) | 10.8±3.5 | 12.2±4.3 |
Procedural data | n= 73 | n= 79 |
Preprocedure antiplatelets | ||
Aspirin | 73 (100.0%) | 79 (100.0%) |
Ticagrelor or clopidogrel | 72 (98.6%) | 79 (100.0%) |
Other antithrombotic agent | 1 (1.4%) | 0 (0.0%) |
Nominal scaffold diameter (mm) | 2.88±0.21 | 2.89±0.21 |
Nominal scaffold length (mm) | 18.1±0.70 | 19.0±2.20 |
Predilatation | 73 (100.0%) | 79 (100.0%) |
Postdilatation | 62 (84.9%) | 70 (88.6%) |
Maximal postdilatation pressure (atm) | 17±4 | 17±5 |
Maximal postdilatation balloon diameter (mm) | 3.15±0.36 | 3.26±0.34 |
Antiplatelets at follow-up | ||
Aspirin | 73 (100.0%) | 78 (98.7%) |
Ticagrelor or clopidogrel | 73 (100.0%) | 79 (100.0%) |
Baseline procedural outcome for patients included in the matched analysis. Values are n (%) or mean±SD.
*One preprocedure image was not available for analysis.
QCA, quantitative coronary arteriography.